Editorial comment on Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate

Abstract

Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.